Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 162 clinical trials
featured
Cognitive Fitness for Depression in Older Adults

antidepressants. The investigators are also interested in whether participating in the treatment will result in changes to brain activity measured with magnetic resonance imaging (MRI).

  • 0 views
  • 23 Mar, 2021
  • 1 location
featured
A Phase 3, Multicenter, Randomized, Double-blind Trial of Fixed-Dose Brexpiprazole as Combination Therapy with Sertraline in the Treatment of Adults with Posttraumatic Stress Disorder

of schizophrenia and as an adjunctive therapy to antidepressants for the treatment of major depressive disorder.Otsuka is conducting this study to find out about the potential

  • 0 views
  • 06 Apr, 2021
  • 1 location
featured
  • 94 views
  • 23 Nov, 2020
  • 1 location
featured
  • 93 views
  • 23 Nov, 2020
  • 1 location
featured
Double-Blind, Placebo-Controlled, Multi-Center Study Investigating the Efficacy, Safety, and Tolerability of JNJ-61393215 as Adjunctive Treatment in Adults with Major Depressive Disorder with Anxious Distress with Suboptimal Response to Standard Antidepressants

Janssen Research & Development is conducting this study to see if their investigational product, JNJ-61393215, is safe and effective for treating patients with Major Depressive Disorder (MDD) with anxious distress who have not had an adequate response to their current antidepressant medication. This study will also evaluate if JNJ-61393215 is …

  • 0 views
  • 06 Apr, 2021
  • 1 location
featured
A Multicenter, Randomized, Flexible-dose, Double-blind Trial of Brexpiprazole Versus Placebo for the Treatment of Adults With Borderline Personality Disorder

schizophrenia and as an adjunctive therapy (add-on therapy) to antidepressants for the treatment of major depressive disorder. The reason for this study is to find out about the potential benefits and safety of

  • 134 views
  • 09 Sep, 2020
  • 1 location
featured
A Double-Blind, Randomized, Parallel-Group Study with Quetiapine Extended Release as Comparator to Evaluate the Efficacy and Safety of Seltorexant 20 mg as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with Major Depressive Disorder with Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy.

Janssen Research & Development is conducting this study is to compare the antidepressant effects of seltorexant (JNJ42847922) to quetiapine extended release (XR) as an add-on treatment to a current antidepressant regimen for patients with major depressive disorder (MDD) with sleep problems (such as difficulty falling asleep, staying asleep or poor …

  • 0 views
  • 06 Apr, 2021
  • 1 location
featured
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole as Adjunctive Therapy in the Maintenance Treatment of Adults With Major Depressive Disorder

schizophrenia and as an adjunctive therapy to antidepressants for the treatment of MDD. Otsuka is conducting this study to find out about the potential benefits and safety of brexpiprazole.

  • 0 views
  • 06 Apr, 2021
  • 1 location
featured
Depression Study

Depression Study

  • 758 views
  • 23 Nov, 2020
  • 1 location
featured
An Investigational Medication for Major Depressive Disorder

An Investigational Medication for Major Depressive Disorder

  • 476 views
  • 08 Nov, 2020
  • 1 location